VC-funded Company:
Signos
Launched in 2018, Signos, Inc. is on a mission to eliminate obesity by igniting the metabolic health movement. Powered by a continuous glucose monitor (CGM), the company's mobile AI-driven system offers personalized insights into how food, movement, sleep, stress, and more affect each unique body. Signos is the only FDA-cleared CGM system for weight management and requires no prescription.
Key Contact
Funding Events
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/28/26 | $20,000,000 |
Blue Cross and Blue Shield of Alabama Dexcom Ventures GV | undisclosed |
